Liver 0 5 0 5 B-clinical_variable
mass 6 10 6 10 I-clinical_variable
( 11 12 11 12 O
> 12 13 12 13 O
= 13 14 13 14 O
1 15 16 15 16 B-lower_bound
cm 17 19 17 19 I-lower_bound
) 19 20 19 20 O
with 21 25 21 25 O
arterial 26 34 26 34 O
phase 35 40 35 40 O
contrast 41 49 41 49 O
enhancement 50 61 50 61 O
and 62 65 62 65 O
early 66 71 66 71 O
washout 72 79 72 79 O
on 80 82 80 82 O
subsequent 83 93 83 93 O
phases 94 100 94 100 O
by 101 103 101 103 O
CT 104 106 104 106 O

Liver 0 5 107 112 B-clinical_variable
mass 6 10 113 117 I-clinical_variable
( 11 12 118 119 O
≥ 12 13 119 120 O
1 14 15 121 122 B-lower_bound
cm 16 18 123 125 I-lower_bound
) 18 19 125 126 O
that 20 24 127 131 O
has 25 28 132 135 O
suggestive 29 39 136 146 O
imaging 40 47 147 154 O
findings 48 56 155 163 O
of 57 59 164 166 O
a 60 61 167 168 O
benign 62 68 169 175 B-cancer
liver 69 74 176 181 I-cancer
mass 75 79 182 186 I-cancer
( 80 81 187 188 O
adenoma 81 88 188 195 B-cancer
, 88 89 195 196 O
hemangioma 90 100 197 207 B-cancer
, 100 101 207 208 O
focal 102 107 209 214 B-cancer
nodular 108 115 215 222 I-cancer
hyperplasia 116 127 223 234 I-cancer
) 127 128 234 235 O

Liver 0 5 236 241 B-clinical_variable
mass 6 10 242 246 I-clinical_variable
( 11 12 247 248 O
≥ 12 13 248 249 O
1 14 15 250 251 B-lower_bound
cm 16 18 252 254 I-lower_bound
) 18 19 254 255 O
that 20 24 256 260 O
is 25 27 261 263 O
a 28 29 264 265 O
non 30 33 266 269 B-cancer
- 33 34 269 270 I-cancer
HCC 34 37 270 273 I-cancer
primary 38 45 274 281 I-cancer
malignancy 46 56 282 292 I-cancer
( 57 58 293 294 O
cholangiocarcinoma 58 76 294 312 B-cancer
) 76 77 312 313 O

Liver 0 5 314 319 B-clinical_variable
mass 6 10 320 324 I-clinical_variable
( 11 12 325 326 O
≥ 12 13 326 327 O
1 14 15 328 329 B-lower_bound
cm 16 18 330 332 I-lower_bound
) 18 19 332 333 O
that 20 24 334 338 O
is 25 27 339 341 O
biopsy 28 34 342 348 B-treatment
proven 35 41 349 355 O
metastatic 42 52 356 366 B-cancer
disease 53 60 367 374 I-cancer
( 61 62 375 376 O
metastatic 62 72 376 386 O
colorectal 73 83 387 397 B-cancer
cancer 84 90 398 404 I-cancer
, 90 91 404 405 O
metastatic 92 102 406 416 O
pancreatic 103 113 417 427 B-cancer
cancer 114 120 428 434 I-cancer
) 120 121 434 435 O

Patients 0 8 436 444 O
with 9 13 445 449 O
a 14 15 450 451 O
known 16 21 452 457 O
infiltrative 22 34 458 470 O
variant 35 42 471 478 O
of 43 45 479 481 O
HCC 46 49 482 485 B-cancer

Patients 0 8 486 494 O
with 9 13 495 499 O
a 14 15 500 501 O
known 16 21 502 507 O
prior 22 27 508 513 O
malignancy 28 38 514 524 B-cancer
who 39 42 525 528 O
have 43 47 529 533 O
received 48 56 534 542 O
systemic 57 65 543 551 B-treatment
chemotherapy 66 78 552 564 I-treatment
within 79 85 565 571 O
five 86 90 572 576 B-upper_bound
years 91 96 577 582 I-upper_bound

Patients 0 8 583 591 O
with 9 13 592 596 O
poorly 14 20 597 603 O
controlled 21 31 604 614 O
diabetes 32 40 615 623 B-chronic_disease
mellitus 41 49 624 632 I-chronic_disease
( 50 51 633 634 O
fasting 51 58 634 641 B-clinical_variable
blood 59 64 642 647 I-clinical_variable
glucose 65 72 648 655 I-clinical_variable
level 73 78 656 661 I-clinical_variable
> 79 80 662 663 O
200 81 84 664 667 B-lower_bound
mg 85 87 668 670 I-lower_bound
/ 87 88 670 671 I-lower_bound
dL 88 90 671 673 I-lower_bound
) 90 91 673 674 O

Pregnant 0 8 675 683 B-pregnancy

Suggestive 0 10 684 694 O
imaging 11 18 695 702 O
findings 19 27 703 711 O
plus 28 32 712 716 O
alpha 33 38 717 722 B-clinical_variable
- 38 39 722 723 I-clinical_variable
feto 39 43 723 727 I-clinical_variable
protein 44 51 728 735 I-clinical_variable
( 52 53 736 737 I-clinical_variable
AFP 53 56 737 740 I-clinical_variable
) 56 57 740 741 I-clinical_variable
> 58 59 742 743 O
200 60 63 744 747 B-lower_bound
mg 64 66 748 750 I-lower_bound
/ 66 67 750 751 I-lower_bound
dL 67 69 751 753 I-lower_bound

Tumor 0 5 754 759 B-cancer
confirmed 6 15 760 769 O
by 16 18 770 772 O
arteriography 19 32 773 786 O

basal 0 5 787 792 B-cancer
cell 6 10 793 797 I-cancer
carcinoma 11 20 798 807 I-cancer
of 21 23 808 810 I-cancer
the 24 27 811 814 I-cancer
skin 28 32 815 819 I-cancer

carcinoma 0 9 820 829 B-cancer
in 10 12 830 832 I-cancer
situ 13 17 833 837 I-cancer
of 18 20 838 840 I-cancer
the 21 24 841 844 I-cancer
cervix 25 31 845 851 I-cancer

patients 0 8 852 860 O
with 9 13 861 865 O
liver 14 19 866 871 B-cancer
mass(es 20 27 872 879 I-cancer
) 27 28 879 880 I-cancer
proven 29 35 881 887 O
to 36 38 888 890 O
be 39 41 891 893 O
metastatic 42 52 894 904 B-cancer
disease 53 60 905 912 I-cancer

prior 0 5 913 918 O
HCC 6 9 919 922 B-cancer

